Small Molecules

01 Mar 2007 Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin Pulsys NDA
01 Mar 2007 Organon and Acrux to develop contraceptive sprays
28 Feb 2007 Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040
28 Feb 2007 Roche and Kosan to Initiate Phase 2 Cancer Development Program With Epothilone R1645 (KOS-1584)
28 Feb 2007 Par Pharmaceutical Returns PAR-101 Marketing Rights To Optimer Pharmaceuticals
28 Feb 2007 Clinical Update - DEBIO-9902 SR (ZT-1) Implant For Alzheimer's Disease
28 Feb 2007 MAP Pharmaceuticals Reports Positive Phase 2 Results for its Pediatric Asthma Drug Candidate
28 Feb 2007 PPD Licenses Statin from Ranbaxy Laboratories
28 Feb 2007 TargeGen Announces Successful Completion of Phase I Clinical Trial Of Topical AMD Drug TG100801
27 Feb 2007 Novartis committed to making Galvus(R) available for patients with type 2 diabetes after US regulators issue ''approvable letter''
27 Feb 2007 TorreyPines Therapeutics Initiates Second Phase I Clinical Trial of NGX426, a Potential Novel Oral Treatment for Chronic Pain Conditions
27 Feb 2007 Astellas Receives a Positive CHMP Opinion for EU Marketing Authorisation for FK506 Modified Release as a Once-Daily Immunosuppressant in Organ Transplantation
27 Feb 2007 LifeCycle Pharma Announces Positive Data from LCP-AtorFen Phase I Clinical Program
27 Feb 2007 Biofrontera has successfully completed a first human trial with its migraine prophylaxis compound BF-1
27 Feb 2007 Palatin Technologies And King Pharmaceuticals Announce Presentation Regarding Clinical Study Evaluating Bremelanotide In Post-Menopausal Female Sexual Dysfunction Patients
27 Feb 2007 'Encouraging' Major Responses Seen With XYOTAX(TM) in Patients With Taxane-Resistant Androgen Independent Prostate Cancer
27 Feb 2007 FDA Approves Cymbalta(R) for Treatment of Generalized Anxiety Disorder
27 Feb 2007 Threshold Pharmaceuticals Announces That a Phase 3 Clinical Trial of Glufosfamide for Treatment of Pancreatic Cancer Did Not Meet Its Primary Endpoint
27 Feb 2007 AstraZeneca Announces New Phase III Study of Vandetanib (ZACTIMA(R), ZD6474) in Patients With Advanced Lung Cancer
27 Feb 2007 GSK initiates first global Phase III study of Tykerb® (lapatinib) in head and neck cancer
27 Feb 2007 Othera Pharmaceuticals Presents New AMD Data at Angiogenesis 2007 Symposium
27 Feb 2007 Senetek PLC Announces Clinical Update on Invicorp(R)
27 Feb 2007 Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent
24 Feb 2007 Shire and New River Pharmaceuticals Announce FDA Approval of the First and Only Stimulant Prodrug VYVANSE(TM) (lisdexamfetamine dimesylate) as a Novel Treatment for ADHD
24 Feb 2007 Gilead Announces Completion of Phase II Clinical Trial of Novel Investigational HIV Integrase Inhibitor GS 9137

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up